Acalabrutinib
Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
ASCO: COVID-19 Medical Resources
NCCN Guidelines for Patients
Leukemia & Lymphoma Society